{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:49:44Z","timestamp":1761709784616,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/25615-6"],"award-info":[{"award-number":["2016\/25615-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Jornal de Pediatria"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jped.2020.10.010","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T16:29:10Z","timestamp":1606235350000},"page":"S67-S74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Human Inborn Errors of Immunity (HIEI): predominantly antibody deficiencies (PADs): if you suspect it, you can detect it"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-0148","authenticated-orcid":false,"given":"Maria Marluce dos Santos","family":"Vilela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jped.2020.10.010_bib0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0245","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/sciimmunol.abb1662","article-title":"Human inborn errors of immunity: an expanding universe","volume":"10","author":"Notarangelo","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global systematic review of primary immunodeficiency registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0255","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12026-018-8996-5","article-title":"Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes","volume":"66","author":"Modell","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.jped.2020.10.010_bib0260","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CMR.00001-09","article-title":"Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections","volume":"22","author":"Fried","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jped.2020.10.010_bib0265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jped.2020.10.010_bib0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","article-title":"X-Linked agammaglobulinaemia: outcomes in the modern era","volume":"183","author":"Shillitoe","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0275","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.waojou.2019.100018","article-title":"X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world","volume":"12","author":"El-Sayed","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jped.2020.10.010_bib0280","first-page":"610","article-title":"Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway","volume":"96","author":"Nomura","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jped.2020.10.010_bib0285","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.humimm.2018.10.015","article-title":"Primary B-cell immunodeficiencies","volume":"80","author":"Smith","year":"2019","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0290","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood.2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jped.2020.10.010_bib0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jped.2020.10.010_bib0300","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","article-title":"Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts","volume":"133","author":"Medical Advisory Committee of the Immune Deficiency Foundation","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4081\/jphr.2013.e3","article-title":"T-cell receptor and K-deleting recombination excision circles in newborn screening of T- and B-cell defects: review of the literature and future challenges","volume":"2","author":"Chiarini","year":"2013","journal-title":"J Public Health Res"},{"key":"10.1016\/j.jped.2020.10.010_bib0310","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaci.2019.11.051","article-title":"Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"146","author":"Lorenzini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0315","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0091-6749(97)70176-3","article-title":"Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family","volume":"100","author":"Kornfeld","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0320","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jped.2020.10.010_bib0325","series-title":"Primary immunodeficiency diseases: a molecular and genetic approach","first-page":"299","article-title":"X-linked agammaglobulinemia and autosomal recessive agammaglobulinemia","author":"Smith","year":"2014"},{"key":"10.1016\/j.jped.2020.10.010_bib0330","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jped.2020.10.010_bib0335","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jped.2020.10.010_bib0340","doi-asserted-by":"crossref","first-page":"e2049","DOI":"10.1002\/rmv.2049","article-title":"Viral infection in primary antibody deficiency syndromes","volume":"29","author":"Jones","year":"2019","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jped.2020.10.010_bib0345","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaip.2015.12.015","article-title":"J Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy","volume":"4","author":"Bearden","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jped.2020.10.010_bib0350","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1038\/s41598-017-06342-5","article-title":"Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency","volume":"7","author":"Mirsafian","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jped.2020.10.010_bib0355","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3389\/fimmu.2018.01826","article-title":"Type I and III interferon productions are impaired in X-Linked agammaglobulinemia patients toward poliovirus but not influenza virus","volume":"9","author":"Luk","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0360","first-page":"181","article-title":"Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients","volume":"13","author":"Amoras","year":"2003","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0365","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.jped.2020.10.010_bib0370","first-page":"632","article-title":"Absence of serum gamma globulins","volume":"84","author":"Bruton","year":"1952","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jped.2020.10.010_bib0375","first-page":"200","volume":"66","author":"Janeway","year":"1953","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.jped.2020.10.010_bib0380","unstructured":"The BTK gene homepage. Available from: https:\/\/databases.lovd.nl\/shared\/genes\/BTK [cited 1.10.2020]."},{"key":"10.1016\/j.jped.2020.10.010_bib0385","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/humu.9060","article-title":"Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia","volume":"20","author":"Tani","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jped.2020.10.010_bib0390","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1590\/S0100-879X2010007500079","article-title":"Mutations of Bruton's tyrosine kinase gene in Brazilian patients with X-linked agammaglobulinemia","volume":"43","author":"Ramalho","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jped.2020.10.010_bib0395","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/iid3.57","article-title":"BTK mutations selectively regulate BTK expression and upregulate monocyte XBP1 mRNA in XLA patients","volume":"3","author":"Teocchi","year":"2015","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jped.2020.10.010_bib0400","unstructured":"European Society for Immunodeficiencies (ESID). ESID registry: working definitions for clinical diagnosis of PID. Available from: https:\/\/esid.org\/Working-Parties\/Registry-Working-Party [cited 1.10.2020]."},{"key":"10.1016\/j.jped.2020.10.010_bib0405","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10875-005-5370-x","article-title":"Severe neutropenia in Japanese patients with x-linked agammaglobulinemia","volume":"25","author":"Kanegane","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0410","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/pai.13263","article-title":"Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover","volume":"31","author":"Soresina","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0415","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0420","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.jaip.2020.08.059","article-title":"Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma","volume":"8","author":"Jin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jped.2020.10.010_bib0425","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom","volume":"82","author":"Halsey","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jped.2020.10.010_bib0430","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1086\/514617","article-title":"Progressive multifocal leukoencephalopathy in a patient with hypogammaglobulinemia","volume":"27","author":"Bezrodnik","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jped.2020.10.010_bib0435","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10875-017-0374-x","article-title":"Gastrointestinal manifestations in X-linked agammaglobulinemia","volume":"37","author":"Barmettler","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0440","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders","volume":"141","author":"Hauck","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0445","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10875-014-0056-x","article-title":"Autoimmunity and inflammation in X-linked agammaglobulinemia","volume":"34","author":"Hernandez-Trujillo","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0450","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM195406172502403","article-title":"Absence of Serum Gamma Globulins in an Adult","volume":"250","author":"Sanford","year":"1954","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jped.2020.10.010_bib0455","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.iac.2020.03.003","article-title":"Chronic lung disease in primary antibody deficiency: diagnosis and management","volume":"40","author":"Maglione","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jped.2020.10.010_bib0460","first-page":"7","article-title":"Neurological manifestations of primary immunodeficiencies","volume":"12","author":"Chavoshzadeh","year":"2018","journal-title":"Iran J Child Neurol"},{"key":"10.1016\/j.jped.2020.10.010_bib0465","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10875-013-9980-4","article-title":"First report of the hyper-IgM syndrome registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes","volume":"34","author":"Cabral-Marques","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jped.2020.10.010_bib0470","first-page":"318","article-title":"Agammaglobulinemia, congenital, acquired and transient forms","volume":"1","author":"Gitlin","year":"1956","journal-title":"Prog Hematol"}],"container-title":["Jornal de Pediatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755720302278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755720302278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T23:21:37Z","timestamp":1758151297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021755720302278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":47,"alternative-id":["S0021755720302278"],"URL":"https:\/\/doi.org\/10.1016\/j.jped.2020.10.010","relation":{},"ISSN":["0021-7557"],"issn-type":[{"type":"print","value":"0021-7557"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Inborn Errors of Immunity (HIEI): predominantly antibody deficiencies (PADs): if you suspect it, you can detect it","name":"articletitle","label":"Article Title"},{"value":"Jornal de Pediatria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jped.2020.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}